Asthma medicine

Abstract

The invention discloses an asthma medicine. The asthma medicine comprises the following components: 5-25 parts of semen lepidii, 10-20 parts of cynanchum glaucescens, 3-18 parts of ginkgo, 3-17 parts of perillaseed, 10-20 parts of bulbus fritilariae, 10-20 parts of ephedra, 2-12 parts of agilawood, and the like, wherein ginger, pinellia ternate, laricifomes officinalis, birthwort, ephedra, perillaseed and cynanchum glaucescens are used as main medicines, and capable of playing the roles of eliminating phlegm and relieving asthma, and effectively treating various asthma and the various symptoms caused by asthma; and the other traditional Chinese medicine ingredients are capable of ensuring the respective pharmaceutical effects, supplementing each other, making good for deficiency, promoting the pharmaceutical effects, and reducing toxic and side effects after being prepared into a decoction.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to an asthma medicine for treating asthma. Background technique [0002] Asthma diseases are mostly due to respiratory system lesions, or inhalation of harmful substances and gases from the outside, including microorganisms, dust, and removal of allergens. There are also diseases of other organs in the body that spread to the lungs through lymph and blood to induce asthma and other diseases. Asthma is a common and frequently-occurring disease that directly endangers human health. The current treatment of asthma mostly adopts a combination of Chinese and Western methods. The drugs mostly use aminophylline, ephedrine, diphenhydramine and antibiotics. Although the disease can be temporarily controlled, it is easy to relapse , and have relatively large side effects; commonly used Chinese patent medicines Qingfei Capsules, Chuanbei Tablets, etc., have a slow curative effect ...

AI Technical Summary

Problems solved by technology

Asthma is a common and frequently-occurring disease that directly endangers human health. The current treatment of asthma mostly adopts a combination of Chinese and Western methods. The drugs mostly use aminophylline, ephedrine, diphenhydramine and antibiotics. Although the disease can be temporarily controlled, it is easy to relapse , and have relatively large side effects; commonly used Chinese patent medicines Qingfei Capsules, Chuanbei Tablets, etc., have slow curative effects and long courses of treatment, and the actual therapeutic effect is not very obvious